Medical Patent Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Experimental Ophthalmology
Study data from Ehime University, Medical Department provide new insights into experimental ophthalmology
January 25th, 2008
"Background To determine the effect of an adrenergic and a cholinergic antagonist on the diameter of the lumen of the nasolacrimal drainage system. Methods The asymptomatic side of 38 patients (29 women, nine men) with unilateral stenosis/obstruction of the nasolacrimal drainage system was studied," scientists in Japan report. "The tear meniscus height (TMH) of the asymptomatic side was normal, and the lacrimal drainage system was patent as revealed by dacryocystography. The nasolacrimal drainage system of the asymptomatic side was infused with 100 mu l of 0.01% bunazosin hydrochloride, a selective alpha-1 adrenergic antagonist, or 100 mu l of 0.4% tropicamide, a...
Source: Medical Patent Business Week (2008-01-25)
|
